Hite Christopher
Insider CIK 1814238 · XLRN Director · RPRX EVP & Vice Chairman · VERA Director · KLRA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RPRX Royalty Pharma plc | S Sale | 2026-09-22 | 2026-09-24 | 3,927 | $58.93 | $231.4K | 270,401 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-09-22 | 2026-09-24 | 96,073 | $58.51 | $5.62M | 274,328 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-09-22 | 2026-09-24 | 3,927 | $58.93 | $231.4K | 270,401 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-09-22 | 2026-09-24 | 96,073 | $58.51 | $5.62M | 274,328 | SEC↗ |
| RPRX Royalty Pharma plc | G Gift | 2026-08-19 | 2026-08-19 | 16,800 | — | $0 | 23,200 | SEC↗ |
| RPRX Royalty Pharma plc | G Gift | 2026-08-19 | 2026-08-19 | 16,800 | — | $0 | 23,200 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-08-18 | 2026-08-19 | 100,000 | $59.97 | $6.00M | 370,401 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-08-18 | 2026-08-19 | 100,000 | $59.97 | $6.00M | 370,401 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2026-08-05 | 2026-08-07 | 11,002 | — | $0 | 470,401 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2026-08-05 | 2026-08-07 | 11,002 | — | $0 | 470,401 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-06-30 | 2026-07-02 | 29,400 | $56.44 | $1.66M | 40,600 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-06-30 | 2026-07-02 | 600 | $57.09 | $34.3K | 40,000 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-06-30 | 2026-07-02 | 97,446 | $56.50 | $5.51M | 461,953 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-06-30 | 2026-07-02 | 2,554 | $57.10 | $145.8K | 459,399 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-06-23 | 2026-06-25 | 32,408 | $54.11 | $1.75M | 676,991 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale | 2026-06-23 | 2026-06-25 | 117,592 | $54.47 | $6.41M | 559,399 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2026-05-06 | 2026-05-08 | 24,263 | — | $0 | 709,399 | SEC↗ |
| KLRA Kailera Therapeutics, Inc. | A Award deriv | 2026-04-16 | 2026-04-20 | 38,300 | — | $0 | 38,300 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2026-03-05 | 2026-03-09 | 24,937 | — | $0 | 24,937 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2026-02-11 | 2026-02-13 | 26,626 | — | $0 | 685,136 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2025-11-05 | 2025-11-07 | 6,168 | — | $0 | 658,510 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2025-08-06 | 2025-08-08 | 3,696 | — | $0 | 652,342 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2025-05-16 | 2025-05-20 | 1,238,789 | — | $0 | 1,238,789 | SEC↗ |
| RPRX Royalty Pharma plc | A Award | 2025-05-08 | 2025-05-09 | 48,646 | — | $0 | 648,646 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2025-02-14 | 2025-02-18 | 30,000 | — | $0 | 86,641 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2025-02-14 | 2025-02-18 | 300,000 | — | $0 | 600,000 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion deriv | 2024-05-13 | 2024-05-16 | 30,000 | — | $0 | 541 | SEC↗ |
| RPRX Royalty Pharma plc | C Conversion | 2024-05-13 | 2024-05-16 | 300,000 | — | $0 | 370,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 1,848 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 10,267 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | U Tender | 2021-11-19 | 2021-11-22 | 930 | — | $0 | 0 | SEC↗ |
| RPRX Royalty Pharma plc | S Sale deriv | 2021-03-23 | 2021-03-25 | 31,959 | $469.86 | $15.02M | 30,541 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2021-01-29 | 2021-02-02 | 1,848 | — | $0 | 1,848 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2021-01-29 | 2021-02-02 | 930 | — | $0 | 930 | SEC↗ |
| RPRX Royalty Pharma plc | P Buy | 2020-06-18 | 2020-06-23 | 70,000 | $28.00 | $1.96M | 70,000 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2020-06-15 | 2020-06-23 | 62,500 | — | $0 | 62,500 | SEC↗ |
| RPRX Royalty Pharma plc | A Award deriv | 2020-06-15 | 2020-06-23 | 116,100 | — | $0 | 116,100 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2020-06-04 | 2020-06-05 | 10,267 | — | $0 | 10,267 | SEC↗ |